Report on trends of incidence (1970???2002) of and mortality (1952???2002) from cancer in Germany, Journal of Cancer Research and Clinical Oncology, vol.88, issue.1, pp.23-35, 2007. ,
DOI : 10.1007/s00432-006-0142-4
International Trends in Colorectal Cancer Incidence Rates, Cancer Epidemiology Biomarkers & Prevention, vol.18, issue.6, pp.1688-1694, 2009. ,
DOI : 10.1158/1055-9965.EPI-09-0090
Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992???2001, Cancer, vol.109, issue.S5, pp.1142-1152, 1992. ,
DOI : 10.1002/cncr.22011
Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates, Annual report to the nation on the status of cancer, pp.544-573, 1975. ,
DOI : 10.1002/cncr.24760
Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s, European Journal of Cancer, vol.44, issue.10, pp.1345-1389, 2008. ,
DOI : 10.1016/j.ejca.2007.12.015
Cancer Statistics, 2010, CA: A Cancer Journal for Clinicians, vol.60, issue.5, pp.277-300, 2010. ,
DOI : 10.3322/caac.20073
Review article: immune suppression and colorectal cancer, Alimentary Pharmacology and Therapeutics, vol.293, issue.2, pp.1163-1177, 2006. ,
DOI : 10.1007/BF01741090
Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L, Blood, vol.106, issue.10, pp.3474-3482, 2005. ,
DOI : 10.1182/blood-2005-03-1327
Randomized Phase II Trial of a Toll-Like Receptor 9 Agonist Oligodeoxynucleotide, PF-3512676, in Combination With First-Line Taxane Plus Platinum Chemotherapy for Advanced-Stage Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.26, issue.24, pp.3979-3986, 2008. ,
DOI : 10.1200/JCO.2007.12.5807
Overall survival benefit for weekly vs. three-weekly taxanes regimens in advanced breast cancer: A meta-analysis, Cancer Treatment Reviews, vol.36, issue.1, pp.69-74, 2010. ,
DOI : 10.1016/j.ctrv.2009.10.006
Toll-like receptors as targets for immune disorders, Trends in Pharmacological Sciences, vol.32, issue.7, pp.435-442, 2011. ,
DOI : 10.1016/j.tips.2011.03.008
Monophosphoryl Lipid A (MPL) as an Adjuvant for Anti-Cancer Vaccines: Clinical Results, Adv Exp Med Biol, vol.667, pp.111-123, 2009. ,
DOI : 10.1007/978-1-4419-1603-7_10
Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4, Immunology, vol.169, issue.2, pp.153-162, 2004. ,
DOI : 10.1038/35085597
Anti-tumor effect of lipopolysaccharide by intradermal administration as a novel drug delivery system, Anticancer Res, vol.17, pp.2153-2158, 1997. ,
Antitumor effect of synthetic derivatives of lipid A in an experimental model of colon cancer in the rat, Gastroenterology, vol.101, issue.3, pp.726-733, 1991. ,
DOI : 10.1016/0016-5085(91)90532-P
Cure of colon cancer metastasis in rats with the new lipid A OM 174 Apoptosis of tumor cells and immunization of rats, Clinical & Experimental Metastasis, vol.17, issue.4, pp.299-306, 1999. ,
DOI : 10.1023/A:1006663017149
Similarities of the Anti-tumour Actions of Endotoxin, Lipid A and Double-stranded RNA, British Journal of Cancer, vol.27, issue.5, pp.370-389, 1973. ,
DOI : 10.1038/bjc.1973.45
Lipid A induced response in vivo.InLipid A in cancer therapy, Edited by Jeannin J, vol.2010, pp.69-80 ,
Correlation between the capacity to activate macrophages in vitro and the antitumor activity in vivo of lipopolysaccharides from different bacterial species, Immunobiology, vol.190, issue.3, pp.243-254, 1994. ,
DOI : 10.1016/S0171-2985(11)80272-X
Role of tumour necrosis factor in the tumour-necrotizing activity of agents with diverging toxicity, Cancer Immunology, Immunotherapy, vol.39, issue.2, pp.115-120, 1991. ,
DOI : 10.1007/BF01742539
Mechanisms of the antitumoral effect of lipid A, BioEssays, vol.22, issue.3, pp.284-289, 2002. ,
DOI : 10.1002/bies.10053
Involvement of T lymphocytes in curative effect of a new immunomodulator OM 163 on rat colon cancer metastases, European Journal of Cancer, vol.29, issue.14, pp.2003-2009, 1993. ,
DOI : 10.1016/0959-8049(93)90462-O
Biological activities and antitumor effects of synthetic lipid a analog linked n-acylated serine, International Journal of Immunopharmacology, vol.17, issue.5, pp.425-431, 1995. ,
DOI : 10.1016/0192-0561(95)00014-S
Antitumour effect of OM-174 and Cyclophosphamide on murine B16 melanoma in different experimental conditions, International Immunopharmacology, vol.5, issue.7-8, pp.1205-1212, 2005. ,
DOI : 10.1016/j.intimp.2005.02.013
Downregulation of the proinflammatory cytokine response to endotoxin by pretreatment with the nontoxic lipid A analog SDZ MRL 953 in cancer patients, pp.1673-1683, 1997. ,
Phase I study of ONO-4007, a synthetic analogue of the lipid A moiety of bacterial lipopolysaccharide, Clin Cancer Res, vol.6, pp.397-405, 2000. ,
Phase-I study of intravenous modified lipid A, Cancer Immunology Immunotherapy, vol.18, issue.2, pp.107-112, 1984. ,
DOI : 10.1007/BF00205743
Human experimentation Code of ethics of the World Medical Association. Declaration of Helsinki, Br Med J, vol.2, p.177, 1964. ,
New Guidelines to Evaluate the Response to Treatment in Solid Tumors, JNCI: Journal of the National Cancer Institute, vol.92, issue.3, pp.205-216, 2000. ,
DOI : 10.1093/jnci/92.3.205
ADRB3 Adrenergic Receptor Is a Key Regulator of Human Myometrial Apoptosis and Inflammation During Chorioamnionitis1, Biology of Reproduction, vol.78, issue.3, pp.497-505, 2008. ,
DOI : 10.1095/biolreprod.107.064444
Multiplexed flow cytometric analyses of pro-and antiinflammatory cytokines in the culture media of oxysterol-treated human monocytic cells and in the sera of atherosclerotic patients, Cytometry A, vol.69, pp.359-373, 2006. ,
Relevance of Toll-like receptor-4 polymorphisms in renal transplantation, Kidney International, vol.67, issue.6, pp.2454-2461, 2005. ,
DOI : 10.1111/j.1523-1755.2005.00354.x
Interleukin-2-induced fever in relation to objective tumor response and survival in patients with metastatic melanoma., Journal of Clinical Oncology, vol.28, issue.15_suppl, p.15, 2010. ,
DOI : 10.1200/jco.2010.28.15_suppl.8569
Phase I trial of intravenously administered endotoxin (Salmonella abortus equi) in cancer patients, Cancer Res, vol.51, pp.2524-2530, 1991. ,
Lipid A-Mediated Tolerance and Cancer Therapy, In Lipid A in cancer therapy. Edited by Jeannin J, vol.2010, pp.81-99 ,
DOI : 10.1007/978-1-4419-1603-7_8
Cancer relapse under chemotherapy: Why TLR2/4 receptor agonists can help, European Journal of Pharmacology, vol.563, issue.1-3, pp.1-17, 2007. ,
DOI : 10.1016/j.ejphar.2007.02.018